CTMX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Cytomx Therapeutics Inc (CTMX).


$80.61M Market Cap.

As of 03/06/2025 5:00 PM ET (MRY) • Disclaimer

CTMX Market Cap. (MRY)


CTMX Shares Outstanding (MRY)


CTMX Assets (MRY)


Total Assets

$120.53M

Total Liabilities

$120.99M

Total Investments

$62.57M

CTMX Income (MRY)


Revenue

$138.10M

Net Income

$31.87M

Operating Expense

$113.11M

CTMX Cash Flow (MRY)


CF Operations

-$86.23M

CF Investing

$99.70M

CF Financing

$7.52M

CTMX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

CTMX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$120,533,000 (-40.27%)

$201,792,000 (-22.65%)

$260,891,000 (-23.13%)

$339,411,000 (-5.37%)

Assets Current

$107,305,000 (-41.34%)

$182,936,000 (-22.85%)

$237,102,000 (-23.59%)

$310,301,000 (-4.23%)

Assets Non-Current

$13,228,000 (-29.85%)

$18,856,000 (-20.74%)

$23,789,000 (-18.28%)

$29,110,000 (-15.99%)

Goodwill & Intangible Assets

$1,532,000 (-8.70%)

$1,678,000 (-8.00%)

$1,824,000 (-7.41%)

$1,970,000 (-6.90%)

Shareholders Equity

-$456,000 (99.04%)

-$47,447,000 (44.67%)

-$85,751,000 (-18582.14%)

-$459,000 (94.10%)

Property Plant & Equipment Net

$10,603,000 (-34.46%)

$16,178,000 (-23.04%)

$21,021,000 (-16.99%)

$25,322,000 (-14.00%)

Cash & Equivalents

$39,079,000 (116.05%)

$18,088,000 (-90.70%)

$194,567,000 (-5.75%)

$206,447,000 (7.09%)

Accumulated Other Comprehensive Income

$27,000 (-71.58%)

$95,000 (850.00%)

$10,000 (104.13%)

-$242,000 (-414.89%)

Deferred Revenue

$94,063,000 (-55.70%)

$212,315,000 (-29.54%)

$301,326,000 (5.82%)

$284,760,000 (-10.65%)

Total Investments

$62,571,000 (-60.23%)

$157,338,000 (0%)

$0 (0%)

$99,696,000 (-19.77%)

Investments Current

$62,571,000 (-60.23%)

$157,338,000 (0%)

$0 (0%)

$99,696,000 (-19.77%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$3,103,000 (-9.59%)

$3,432,000 (-90.46%)

$35,986,000 (4455.19%)

$790,000 (-1.00%)

Trade & Non-Trade Payables

$1,088,000 (-25.38%)

$1,458,000 (-48.10%)

$2,809,000 (-0.32%)

$2,818,000 (-5.94%)

Accumulated Retained Earnings (Deficit)

-$691,579,000 (4.41%)

-$723,448,000 (-0.08%)

-$722,879,000 (-15.93%)

-$623,562,000 (-22.82%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$9,385,000 (-32.84%)

$13,974,000 (-0.01%)

$13,975,000 (-22.60%)

$18,056,000 (-16.70%)

Debt Current

$5,145,000 (12.12%)

$4,589,000 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$4,240,000 (-54.82%)

$9,385,000 (-32.84%)

$13,975,000 (-22.60%)

$18,056,000 (-16.70%)

Total Liabilities

$120,989,000 (-51.46%)

$249,239,000 (-28.10%)

$346,642,000 (1.99%)

$339,870,000 (-7.25%)

Liabilities Current

$85,772,000 (-44.99%)

$155,913,000 (2.17%)

$152,608,000 (95.98%)

$77,870,000 (14.33%)

Liabilities Non-Current

$35,217,000 (-62.26%)

$93,326,000 (-51.90%)

$194,034,000 (-25.94%)

$262,000,000 (-12.18%)

CTMX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$138,103,000 (36.45%)

$101,214,000 (90.38%)

$53,163,000 (42.48%)

$37,312,000 (-45.47%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$29,726,000 (-0.97%)

$30,018,000 (-29.94%)

$42,849,000 (9.42%)

$39,160,000 (8.68%)

Research & Development Expense

$83,382,000 (7.34%)

$77,680,000 (-30.42%)

$111,649,000 (-2.23%)

$114,194,000 (1.11%)

Operating Expenses

$113,108,000 (5.02%)

$107,698,000 (-30.29%)

$154,498,000 (0.75%)

$153,354,000 (2.94%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$224,000 (-94.24%)

$3,892,000 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$31,869,000 (5700.88%)

-$569,000 (99.43%)

-$99,317,000 (14.29%)

-$115,870,000 (-78.76%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$31,869,000 (5700.88%)

-$569,000 (99.43%)

-$99,317,000 (14.29%)

-$115,870,000 (-78.76%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$31,869,000 (5700.88%)

-$569,000 (99.43%)

-$99,317,000 (14.29%)

-$115,870,000 (-78.76%)

Weighted Average Shares

$84,439,303 (14.40%)

$73,808,237 (12.27%)

$65,739,844 (2.48%)

$64,146,848 (39.01%)

Weighted Average Shares Diluted

$84,745,116 (14.82%)

$73,808,237 (12.27%)

$65,739,844 (2.48%)

$64,146,848 (39.01%)

Earning Before Interest & Taxes (EBIT)

$32,093,000 (865.78%)

$3,323,000 (103.35%)

-$99,317,000 (14.29%)

-$115,870,000 (-47.17%)

Gross Profit

$138,103,000 (36.45%)

$101,214,000 (90.38%)

$53,163,000 (42.48%)

$37,312,000 (-45.47%)

Operating Income

$24,995,000 (485.49%)

-$6,484,000 (93.60%)

-$101,335,000 (12.67%)

-$116,042,000 (-44.08%)

CTMX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$99,700,000 (166.17%)

-$150,674,000 (-253.34%)

$98,260,000 (336.92%)

$22,489,000 (220.15%)

Net Cash Flow from Financing

$7,522,000 (-75.12%)

$30,230,000 (4565.12%)

$648,000 (-99.41%)

$110,213,000 (552.42%)

Net Cash Flow from Operations

-$86,231,000 (-53.89%)

-$56,035,000 (49.42%)

-$110,788,000 (6.93%)

-$119,031,000 (-2363.38%)

Net Cash Flow / Change in Cash & Cash Equivalents

$20,991,000 (111.89%)

-$176,479,000 (-1385.51%)

-$11,880,000 (-186.90%)

$13,671,000 (298.11%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$100,010,000 (166.75%)

-$149,834,000 (-249.83%)

$100,000,000 (314.97%)

$24,098,000 (246.86%)

Capital Expenditure

-$310,000 (63.10%)

-$840,000 (51.72%)

-$1,740,000 (-8.14%)

-$1,609,000 (30.32%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$7,522,000 (-75.12%)

$30,230,000 (4565.12%)

$648,000 (-99.41%)

$110,213,000 (552.42%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$7,668,000 (-10.40%)

$8,558,000 (-34.80%)

$13,125,000 (-0.32%)

$13,167,000 (-10.95%)

Depreciation Amortization & Accretion

$5,852,000 (-0.88%)

$5,904,000 (0.82%)

$5,856,000 (0.29%)

$5,839,000 (6.94%)

CTMX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

23.10% (3950.00%)

-0.60% (99.68%)

-186.80% (39.84%)

-310.50% (-227.88%)

EBITDA Margin

27.50% (202.20%)

9.10% (105.18%)

-175.80% (40.39%)

-294.90% (-175.35%)

Return on Average Equity (ROAE)

-146.80% (-18450.00%)

0.80% (100.12%)

-666.30% (-458.04%)

-119.40% (22.21%)

Return on Average Assets (ROAA)

21.10% (7133.33%)

-0.30% (99.21%)

-38.00% (-26.67%)

-30.00% (-81.82%)

Return on Sales (ROS)

23.20% (603.03%)

3.30% (101.77%)

-186.80% (39.84%)

-310.50% (-169.77%)

Return on Invested Capital (ROIC)

-1013.20% (-11745.98%)

8.70% (101.34%)

-649.40% (-203.46%)

-214.00% (-222.29%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

2.71 (101.75%)

-155 (-14522.64%)

-1.06 (55.69%)

-2.39 (48.88%)

Price to Sales Ratio (P/S)

0.63 (-44.25%)

1.13 (-42.90%)

1.98 (-73.41%)

7.44 (68.53%)

Price to Book Ratio (P/B)

-176.77 (-7979.02%)

-2.19 (-77.45%)

-1.23 (99.80%)

-615.53 (-1480.47%)

Debt to Equity Ratio (D/E)

-265.33 (-4950.96%)

-5.25 (-29.96%)

-4.04 (99.45%)

-740.46 (-1470.90%)

Earnings Per Share (EPS)

0.38 (3900.00%)

-0.01 (99.34%)

-1.51 (16.57%)

-1.81 (-29.29%)

Sales Per Share (SPS)

1.64 (19.33%)

1.37 (69.47%)

0.81 (39.00%)

0.58 (-60.76%)

Free Cash Flow Per Share (FCFPS)

-1.02 (-32.94%)

-0.77 (54.96%)

-1.71 (8.98%)

-1.88 (-3039.06%)

Book Value Per Share (BVPS)

-0.01 (99.22%)

-0.64 (50.69%)

-1.3 (-18528.57%)

-0.01 (95.83%)

Tangible Assets Book Value Per Share (TABVPS)

1.41 (-48.03%)

2.71 (-31.21%)

3.94 (-25.08%)

5.26 (-31.93%)

Enterprise Value Over EBIT (EV/EBIT)

2 (-92.31%)

26 (0%)

0 (0%)

-1 (50.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

1.31 (-86.22%)

9.48 (3664.66%)

-0.27 (54.53%)

-0.58 (70.95%)

Asset Turnover

0.92 (95.93%)

0.47 (128.92%)

0.2 (112.50%)

0.1 (-44.83%)

Current Ratio

1.25 (6.65%)

1.17 (-24.52%)

1.55 (-61.00%)

3.98 (-16.23%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$86,541,000 (-52.16%)

-$56,875,000 (49.46%)

-$112,528,000 (6.72%)

-$120,640,000 (-4189.49%)

Enterprise Value (EV)

$49,600,645 (-43.31%)

$87,488,801 (252.25%)

$24,836,987 (-61.40%)

$64,344,672 (-56.40%)

Earnings Before Tax (EBT)

$32,093,000 (865.78%)

$3,323,000 (103.35%)

-$99,317,000 (14.29%)

-$115,870,000 (-47.17%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$37,945,000 (311.24%)

$9,227,000 (109.87%)

-$93,461,000 (15.06%)

-$110,031,000 (-50.17%)

Invested Capital

$3,535,000 (-91.18%)

$40,087,000 (154.07%)

-$74,133,000 (-204.15%)

$71,180,000 (-39.34%)

Working Capital

$21,533,000 (-20.32%)

$27,023,000 (-68.02%)

$84,494,000 (-63.65%)

$232,431,000 (-9.17%)

Tangible Asset Value

$119,001,000 (-40.53%)

$200,114,000 (-22.76%)

$259,067,000 (-23.23%)

$337,441,000 (-5.36%)

Market Capitalization

$80,606,645 (-22.37%)

$103,832,801 (-1.80%)

$105,734,987 (-62.58%)

$282,528,672 (-6.69%)

Average Equity

-$21,703,750 (67.89%)

-$67,587,250 (-553.42%)

$14,906,250 (-84.64%)

$97,047,500 (129.85%)

Average Assets

$150,855,000 (-30.38%)

$216,693,500 (-17.00%)

$261,073,500 (-32.51%)

$386,810,500 (-1.64%)

Invested Capital Average

-$3,167,500 (-108.28%)

$38,233,250 (149.98%)

$15,294,250 (-71.75%)

$54,145,750 (-54.31%)

Shares

78,258,879 (16.82%)

66,988,904 (1.37%)

66,084,367 (1.28%)

65,249,116 (41.16%)